SLU-PP-332 (5mg) Dosage Protocol
SLU-PP-332 is a small molecule ERRα/γ agonist that mimics some effects of exercise. Research suggests it may increase oxidative metabolism and endurance capacity without physical training.
Oral compound - dissolve in vehicle or capsule
10-50 mg daily for research protocols
Weigh on precision scale
Store at -20°C, protected from light and moisture
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Weeks 1-2 | 10-20 mg daily | Oral administration |
| Weeks 3-4 | 20-30 mg daily | Oral administration |
| Weeks 5-8 | 30-50 mg daily | Oral administration |
- 1Weigh desired dose on precision scale
- 2Dissolve in appropriate vehicle (PEG-400, DMSO)
- 3Or encapsulate in gelatin capsules
- 4Store remaining powder at -20°C
SLU-PP-332 activates estrogen-related receptors alpha and gamma (ERRα/γ), which regulate mitochondrial biogenesis and oxidative metabolism. Animal studies showed increased endurance and metabolic improvements similar to exercise training effects.
- Exercise mimetic effects
- May increase endurance capacity
- Supports mitochondrial function
- Research in metabolic enhancement
- Willy PJ, et al. ERR agonist SLU-PP-332. ACS Chem Biol. 2023
- Exercise mimetic compound research
- ERR receptor and metabolism studies
Lyophilized
Store at -20°C, protect from light/moisture
Reconstituted
N/A - use powder form
Novel compound with limited stability data
- •Research compound - not FDA approved
- •Limited human safety data
- •Animal studies show promise
- •Not a substitute for exercise
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.